ENTRY       D04295                      Drug
NAME        Galiximab (USAN/INN)
EFFICACY    Antipsoriatic, Anti-CD80 antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of psoriasis
TARGET      CD80 [HSA:941] [KO:K05412]
  PATHWAY   hsa04514(941)  Cell adhesion molecules
            hsa04620(941)  Toll-like receptor signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Other cell surface molecules
               CD molecules
                CD80
                 D04295  Galiximab (USAN/INN)
DBLINKS     CAS: 357613-77-5
            PubChem: 47206227
            NIKKAJI: J2.415.691E
///
